{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2F094d1177-52aa-4cb4-9983-1597422eb78c","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"Why the Conventional Wisdom Regarding \u2018R\u2019 and \u2018D\u2019 in Medtech Product Development Is Wrong\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/094d1177-52aa-4cb4-9983-1597422eb78c\"></iframe>","title":"Why the Conventional Wisdom Regarding \u2018R\u2019 and \u2018D\u2019 in Medtech Product Development Is Wrong","description":"Today on the Global Medical Device Podcast we have a very interesting and highly debated topic for you around research vs. development for medical device companies.\n\nWe\u2019ll challenge some conventional wisdom on the subject and dig into when \u2018R\u2019 should end and \u2018D\u2019 begin. \n\nOur guest on the show today is David Amor, a medtech/biotech consultant and mobile health entrepreneur. David is the founder of Medgineering, a consultancy specializing in implementing new quality systems, design control processes, and risk management for both startups and larger companies.\nRecently David also launched QuickConsult, an online consulting platform that pairs up medtech experts with startups or large companies. The online consulting model allows clients to work with the consultants of their choice who will help them understand their specific quality and regulatory needs.\nThe subject of today\u2019s episode is loosely based on a well written and thoughtful article David authored a few months back titled, \u201cWhen does the \u2018R\u2019 end and the \u2018D\u2019 begin for medical device companies?\u201d\nJon and David touch upon a lot of the points in that post (which I encourage you to go read after listening to today\u2019s episode) and really dig into why the conventional wisdom regarding \u2018R\u2019 and \u2018D\u2019 in medical device product development is often wrong.\n\nSpecifically, today Jon and David get into:\n\n-Why should you start design controls early in development?\n-Are your thoughts about research wrong?\n-Will doing design controls early slow you down?\n-When do design controls ACTUALLY start?\n-How to view design controls as more than a paperwork heavy process.\n-The shift in traditional R&D roles.\n-What outcomes you should be focused on BEFORE research.","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/ce6780cd-7ee7-439c-b034-c45096769efc/3ae7084e-762e-4860-89fd-205b5a0da5e7.jpg"}